1. Arrhythmia induced by clozapine in patients with schizophrenia: a Meta-analysis
- Author
-
Chen Yadi, Ding Yu, Li Qianqian, Liu Xiaolei, and Wang Weiwei
- Subjects
clozapine ,schizophrenia ,arrhythmias ,meta-analysis ,Psychology ,BF1-990 ,Psychiatry ,RC435-571 - Abstract
BackgroundClozapine belongs to atypical antipsychotic drugs that has shown significant efficacy in treating schizophrenia. However, clozapine can induce arrhythmias in patients. Currently, there is a lack of systematic research on the types and incidence of clozapine-induced arrhythmias.ObjectiveTo explore the types and incidence of arrhythmias in patients with schizophrenia induced by clozapine through Meta-analysis, so as to provide references for clinical treatment.MethodsOn October 31, 2022, a search was conducted through PubMed, Embase, Cochrane Library and China National Knowledge Infrastructure (CNKI) to collect relevant literature on clozapine-induced arrhythmia in patients with schizophrenia. Joanna Briggs Institute (JBI) was used to evaluate the quality of the included literature. Meta-analysis was conducted using Review Manager 5.4.ResultsA total of 12 studies were included, involving 42 490 schizophrenia patients taking clozapine. The incidence of arrhythmias caused by clozapine was 23% (95% CI: 0.16~0.29). Among them, the incidence of tachycardia was 25% (95% CI: 0.15~0.35), atrial arrhythmia was 6% (95% CI: -0.02~0.14), ventricular arrhythmia was 7% (95% CI: -0.02~0.16), conduction block was 2% (95% CI: 0~0.04), QTc prolongation was 4% (95% CI: -0.04~0.12) and T-wave changes was 23% (95% CI: 0.16~0.30).ConclusionSchizophrenia patients taking clozapine may increase their risk of developing arrhythmia, with tachycardia being the most prevalent. [Funded by Graduate Innovation Fund of Kunming Medical University (number, 2023S302)]
- Published
- 2024
- Full Text
- View/download PDF